Biotech · Private company
Asana BioSciences
Track this companyFree. Adds Asana BioSciences to your Dealase workspace and tells you when its record changes.
Clinical trials100 recruiting or active
Pipeline programs12From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline12
- ASN002Phase 2 · Atopic DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- ASN002Phase 2 · Chronic Hand DermatitisClinicalTrials.gov · fetched Nov 12, 2026
- ASN002 Dose EscalationPhase 2 · Lymphoma, Large B-Cell, DiffuseClinicalTrials.gov · fetched Nov 12, 2026
- ASN002 RDPhase 2 · Lymphoma, Large B-Cell, DiffuseClinicalTrials.gov · fetched Nov 12, 2026
- [14C] ASN002Phase 1 · Healthy VolunteerClinicalTrials.gov · fetched Nov 12, 2026
- ASN002Phase 1 · Healthy VolunteersClinicalTrials.gov · fetched Nov 12, 2026
- ASN002Phase 1 · Dermatitis, AtopicClinicalTrials.gov · fetched Nov 12, 2026
- ASN003 ascending dosesPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- ASN003 MTDPhase 1 · NeoplasmsClinicalTrials.gov · fetched Nov 12, 2026
- ASN007 RDPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- ASN007: ascending dosesPhase 1 · CancerClinicalTrials.gov · fetched Nov 12, 2026
- ASN008 TGPhase 1 · Dermatitis, AtopicClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials10
- Study to Evaluate ASN008 Topical Gel (TG)PHASE1 · COMPLETED · started Jan 14, 2019ClinicalTrials.gov NCT03798561 · fetched Nov 12, 2026
- Study to Evaluate ASN002 in Subjects With Moderate To Severe Chronic Hand EczemaPHASE2 · COMPLETED · started Jan 3, 2019ClinicalTrials.gov NCT03728504 · fetched Nov 12, 2026
- Phase 1 Study to Evaluate ASN002 Absorption, Metabolism, and Excretion of [14C] Following a Single Oral Dose in Healthy Male SubjectsPHASE1 · COMPLETED · started Oct 11, 2018ClinicalTrials.gov NCT03641573 · fetched Nov 12, 2026
- Study to Evaluate Long-Term Safety of ASN002 in Subjects With Moderate to Severe Atopic DermatitisPHASE2 · TERMINATED · started Sep 29, 2018ClinicalTrials.gov NCT03654755 · fetched Nov 12, 2026
- Phase 2B Study to Evaluate ASN002 in Subjects With Moderate to Severe Atopic Dermatitis (RADIANT)PHASE2 · COMPLETED · started Jul 5, 2018ClinicalTrials.gov NCT03531957 · fetched Nov 12, 2026
- A Study of ASN007 in Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Jan 19, 2018ClinicalTrials.gov NCT03415126 · fetched Nov 12, 2026
- A Study To Evaluate ASN002 In Subjects With Atopic DermatitisPHASE1 · COMPLETED · started Apr 12, 2017ClinicalTrials.gov NCT03139981 · fetched Nov 12, 2026
- Study of ASN003 in Subjects With Advanced Solid TumorsPHASE1 · TERMINATED · started Oct 1, 2016ClinicalTrials.gov NCT02961283 · fetched Nov 12, 2026
- Single Ascending Dose Study to Evaluate Pharmacokinetics and Food-Effect in Healthy VolunteersPHASE1 · COMPLETED · started Jul 1, 2016ClinicalTrials.gov NCT02853643 · fetched Nov 12, 2026
- A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid TumorsPHASE1_PHASE2 · TERMINATED · started May 1, 2015ClinicalTrials.gov NCT02440685 · fetched Nov 12, 2026